Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 15, 2013
A national audit of current cardiac device policies from radiotherapy centres across the UKJ F Lester, L M Evans, Z Yousef, et al.Clinical Endocrinology|April 23, 2002
Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiencyJamie C Smith, D Lang, J McEneny, et al.The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
The effects of depot long-acting somatostatin analog on central aortic pressure and arterial stiffness in acromegalyJ C Smith, H Lane, N Davies, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2011
A longitudinal study into the new and long-term use of self-monitoring blood glucose strips in the UKC L Morgan, A Griffin, G H Chamberlain, et al.Clinical Endocrinology|November 18, 2003
The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemiaL P Pinto, F W F Hanna, L M Evans, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedulesS S Legha, N E Papadopoulos, C Plager, et al.Clinical Endocrinology|April 23, 2002
Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled studyJamie C Smith, L M Evans, I Wilkinson, et al.Journal of Interferon Research|September 1, 1989
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon-alpha 2aL M Itri, M I Sherman, A V Palleroni, et al.Thyroid : Official Journal of the American Thyroid Association|October 18, 2006
Peripheral cytokine expression in autoimmune thyroiditis: effects of in vitro modulation by rosiglitazone and dexamethasoneO E Okosieme, A B Parkes, L D K E Premawardhana, et al.Clinical Endocrinology|June 21, 2005
Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomasM Biswas, J Smith, D Jadon, et al.Pageof 5